A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab In Patients With Recurrent Or Metastatic Head and Neck Cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin; Cisplatin; Docetaxel; Fluorouracil
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 02 Feb 2018 Planned primary completion date changed from 31 Jan 2018 to 28 Feb 2018.
- 21 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 31 Jan 2018.
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology